NCT00004091View on ClinicalTrials.gov

Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Cervical Cancer
Interventions
OTHER

Papanicolaou test

OTHER

cytology specimen collection procedure

OTHER

fluorescent antibody technique

PROCEDURE

colposcopic biopsy

PROCEDURE

study of high risk factors

Trial Locations (1)

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Northwestern University

OTHER

NCT00004091 - Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results | Biotech Hunter | Biotech Hunter